Delta Lloyd’s Allergan plc AGN Stock Holding History

Delta Lloyd’s Portfolio AGN Stock Details AGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2013 Q4	–	Sell	-3,675	Closed	-$529K	–	624
2013 Q3	$529K	Buy	3,675 +817	+29%	+$109K	0.02%	324
2013 Q2	$361K	Buy	+2,858	New	+$324K	0.01%	385

Other funds holding AGN

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return

Sculptor Capital New York $9.61B AUM 27.49% 1-Year Est. Return

OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Delta Lloyd's AGN Position: Q4 2013 in Review

Delta Lloyd sold out of Allergan plc (AGN) in Q4 2013, closing a stake of 3,675 shares — an estimated $529K sold.

Delta Lloyd first reported a position in AGN in Q2 2013 and held it in 2 quarters. The position peaked at $529K in Q3 2013. 552 funds tracked by Wall St. Rank hold AGN as of Q4 2013.

Delta Lloyd reported no remaining Allergan plc position as of Q4 2013 after selling out during the quarter.
Delta Lloyd sold 3,675 Allergan plc shares in Q4 2013, an estimated $529K.
Delta Lloyd first reported a position in Allergan plc in Q2 2013 and held it in 2 quarters.
Delta Lloyd's Allergan plc position peaked at $529K in Q3 2013.
552 funds tracked by Wall St. Rank held Allergan plc as of Q4 2013.

Based on Delta Lloyd's 13F filing for Q4 2013, filed 12 Feb 2014.